It was earlier reported that sericin inhibits breast cancer cell (triple negative breast cancer; TNBC) proliferation via the PI3-K/Akt pathway, by inducing cell cycle arrest and promoting cellular apoptosis25. Here, AKT1 is linked to breast carcinoma.